未分化甲状腺癌长期生存者的基因组预测模型
CONTEXT: Longer-term survival is possible for some patients with anaplastic thyroid cancer (ATC). However, genomic factors associated with improved survival are poorly characterized. OBJECTIVE: To develop a mathematical model to predict mutation-based survival risk in ATC.…
要点
- 风险评分阈值0.27区分侵袭性更强与较弱队列,1年生存率分别为0%与32%。
- 模型C-index为0.74,验证队列及BRAF亚组分析中风险分层生存差异仍显著。
核心结论
- 该模型识别与最具侵袭性ATC相关的突变基因,可能有助于术前评估患者是否适合以治愈为目的的手术。
研究设计与样本
- 回顾性队列研究,纳入cBioPortal数据库204例ATC样本,分为80%训练队列和20%验证队列。
- 采用多变量分析识别预后基因,构建基于评分的风险模型,并进行KEGG通路富集和BRAF亚组分析。
主要发现
- 使用最大选择秩统计量确定评分阈值0.27,划分出更具侵袭性队列(n=37)和侵袭性较弱队列(n=128)。
- 风险模型预测性能C-index为0.74。
- Kaplan-Meier分析显示,更具侵袭性患者1年生存率为0%,侵袭性较弱患者为32%。
- 验证队列中风险队列间生存仍显著不同,BRAF亚组分析亦如此。
关键数值与推荐
- 风险评分阈值0.27用于区分更具侵袭性与侵袭性较弱队列。
- 更具侵袭性队列(n=37)1年生存率为0%,侵袭性较弱队列(n=128)为32%。
- 模型C-index为0.74。
临床怎么用
- 该模型可能辅助术前风险分层,帮助评估ATC患者以治愈为目的手术的适宜性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Longer-term survival is possible for some patients with anaplastic thyroid cancer (ATC). However, genomic factors associated with improved survival are poorly characterized. OBJECTIVE: To develop a mathematical model to predict mutation-based survival risk in ATC. DESIGN: Retrospective cohort study of 204 ATC samples from the cBioPortal database, divided into 80% training and 20% validation cohorts. Multivariate analysis identified prognostic genes, used to construct a point-based risk model. KEGG pathway enrichment and BRAF subanalyses were performed. SETTING: Multi-institutional, international genomic database. PATIENTS OR OTHER PARTICIPANTS: Samples were included if sequencing and survival data were available (n = 204). INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): The prespecified primary outcome was overall survival. RESULTS: Fourteen genes were associated with increased risk: TET1, MAPK12, ATP10A, PIK3CA, MUC4, PNPLA2, PLD4, EGLN2, BSN, FLNC, RADIL, ZMYND8, FRAS1, RECQL4. More aggressive (n = 37) and less aggressive cohorts (n = 128) were determined using the maximally selected rank statistic, yielding a point threshold of 0.27. The predictive performance of the risk model demonstrated a C-index of 0.74. On Kaplan-Meier analysis, 1-year survival differed for more aggressive patients (0%) compared to less aggressive patients (32%). For the validation cohort, survival remained significantly different between risk cohorts and on BRAF subanalysis. Each risk cohort subsequently underwent KEGG pathway enrichment analysis, which showed significantly increased enrichment across several pathways for more aggressive tumors. CONCLUSION: This model identifies mutated genes that are associated with the most aggressive ATCs and thus may aid in preoperative risk assessment when evaluating patients for surgery for curative intent.
引用
- Greenspun BC, Metzger DA, Lee S, et al. Long-term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model. J Clin Endocrinol Metab. 2026. PMID: 40663630. doi:10.1210/clinem/dgaf391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。